Physiological tissue microenvironment

The physiological tissue microenvironment is the complex, localized ecosystem surrounding cells, encompassing the extracellular matrix (ECM), interstitial fluid, signaling molecules, and various stromal and immune cell types (Source: Nature Reviews Molecular Cell Biology, 2021). It plays a fundamental role in maintaining tissue homeostasis by providing structural scaffolding and biochemical cues that regulate cell survival, proliferation, and differentiation (Source: Science, 2009). Furthermore, the physical properties of the microenvironment, such as interstitial fluid pressure and matrix density, significantly influence the transport and distribution of therapeutic agents within the tissue (Source: Nature Reviews Cancer, 2014). In disease states, particularly cancer and fibrosis, the microenvironment is often pathologically altered, exhibiting features such as hypoxia, increased stiffness, and an immunosuppressive cytokine profile that facilitates disease progression (Source: NIH National Cancer Institute). While the microenvironment is a systemic concept rather than a single molecular entity, it contains numerous specific targets for therapeutic intervention, including growth factors like VEGF and immune checkpoints like PD-1. Strategies to modulate the microenvironment aim to normalize the tissue niche, thereby improving drug delivery and restoring normal cellular function (Source: Current Biology, 2020).

Other names

Tissue microenvironmentCellular microenvironmentNicheExtracellular microenvironmentTumor microenvironment

Modulation of the extracellular matrix, inhibition of pro-angiogenic signaling, and alteration of the local immune and biochemical landscape to restore homeostasis or enhance therapeutic access.